269 related articles for article (PubMed ID: 17040103)
21. Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey.
Johnson BM; Kamath AV; Leet JE; Liu X; Bhide RS; Tejwani RW; Zhang Y; Qian L; Wei DD; Lombardo LJ; Shu YZ
Drug Metab Dispos; 2008 Dec; 36(12):2475-83. PubMed ID: 18787055
[TBL] [Abstract][Full Text] [Related]
22. [Effect of modifiers of the cytochrome P-450-dependent enzyme system of the liver on the metabolic pathways of diethylnitrosamine activation and inactivation].
Shuliakovskaia TS; Koen IaM; Rykova VA; Loknitskaia NN; Fonshteĭn LM
Vopr Onkol; 1987; 33(1):78-83. PubMed ID: 3544492
[TBL] [Abstract][Full Text] [Related]
23. In vitro metabolism of 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] acetic acid (licofelone, ML3000), an inhibitor of cyclooxygenase-1 and -2 and 5-lipoxygenase.
Albrecht W; Unger A; Nussler AK; Laufer S
Drug Metab Dispos; 2008 May; 36(5):894-903. PubMed ID: 18268076
[TBL] [Abstract][Full Text] [Related]
24. 1H-indazole and 2H-indazole derivatives of androsta-5,16-dien-3beta-ol.
Silva MR; Moreira VM; Cardoso C; Beja AM; Salvador JA
Acta Crystallogr C; 2008 Apr; 64(Pt 4):o217-9. PubMed ID: 18391393
[TBL] [Abstract][Full Text] [Related]
25. Bacterial mutagenicity of the three isomeric dicyclopenta-fused pyrenes: the effects of dicyclopenta topology.
Otero-Lobato MJ; Jenneskens LW; Seinen W
Mutat Res; 2004 Apr; 559(1-2):105-19. PubMed ID: 15066579
[TBL] [Abstract][Full Text] [Related]
26. Review of the Salmonella typhimurium mutagenicity of benzidine, benzidine analogues, and benzidine-based dyes.
Chung KT; Chen SC; Claxton LD
Mutat Res; 2006 Jan; 612(1):58-76. PubMed ID: 16198141
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes.
Minato K; Suzuki R; Asagarasu A; Matsui T; Sato M
Drug Metab Dispos; 2008 May; 36(5):831-40. PubMed ID: 18238859
[TBL] [Abstract][Full Text] [Related]
28. A novel bioactivation pathway for 2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoic acid (diclofenac) initiated by cytochrome P450-mediated oxidative decarboxylation.
Grillo MP; Ma J; Teffera Y; Waldon DJ
Drug Metab Dispos; 2008 Sep; 36(9):1740-4. PubMed ID: 18541695
[TBL] [Abstract][Full Text] [Related]
29. Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen.
O'Donnell JP; Dalvie DK; Kalgutkar AS; Obach RS
Drug Metab Dispos; 2003 Nov; 31(11):1369-77. PubMed ID: 14570769
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of mutagenic and antimutagenic activities of alpha-bisabolol in the Salmonella/microsome assay.
Gomes-Carneiro MR; Dias DM; De-Oliveira AC; Paumgartten FJ
Mutat Res; 2005 Aug; 585(1-2):105-12. PubMed ID: 15936245
[TBL] [Abstract][Full Text] [Related]
31. 3-Aminobenzamide: effects on cytochrome P450-dependent metabolism of chemicals and on the toxicity of dichlobenil in the olfactory mucosa.
Eriksson C; Busk L; Brittebo EB
Toxicol Appl Pharmacol; 1996 Feb; 136(2):324-31. PubMed ID: 8619240
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of rofecoxib in vitro using human liver subcellular fractions.
Slaughter D; Takenaga N; Lu P; Assang C; Walsh DJ; Arison BH; Cui D; Halpin RA; Geer LA; Vyas KP; Baillie TA
Drug Metab Dispos; 2003 Nov; 31(11):1398-408. PubMed ID: 14570773
[TBL] [Abstract][Full Text] [Related]
33. Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108.
Miyazaki M; Sugawara E; Yoshimura T; Yamazaki H; Kamataki T
Mutat Res; 2005 Mar; 581(1-2):165-71. PubMed ID: 15725615
[TBL] [Abstract][Full Text] [Related]
34. Novel metabolic bioactivation mechanism for a series of anti-inflammatory agents (2,5-diaminothiophene derivatives) mediated by cytochrome p450 enzymes.
Hu Y; Yang S; Shilliday FB; Heyde BR; Mandrell KM; Robins RH; Xie J; Reding MT; Lai Y; Thompson DC
Drug Metab Dispos; 2010 Sep; 38(9):1522-31. PubMed ID: 20530221
[TBL] [Abstract][Full Text] [Related]
35. Studies on the mutagenicity of mild gasification products of coal and their subfractions by the Salmonella/microsomal assay.
Zhong BZ; Stamm SC; Robbins S; Bryant D; Lan W; Xin WF; Ma JK; Whong WZ; Ong TM
Environ Res; 1997 Jan; 72(1):32-44. PubMed ID: 9012370
[TBL] [Abstract][Full Text] [Related]
36. Bioactivation of a dihydropyrazole-1-carboxylic acid-(4-chlorophenyl amide) scaffold to a putative p-chlorophenyl isocyanate in rat liver microsomes and in vivo in rats.
Chen H; Zhang Y; Edmunds J; Bigge C; Mutlib A
Chem Res Toxicol; 2008 May; 21(5):1095-106. PubMed ID: 18393453
[TBL] [Abstract][Full Text] [Related]
37. The metabolic activation of 2-aminofluorine, 4-aminobiphenyl, and benzidine by cytochrome P-450-107S1 of Pseudomonas aeruginosa.
Adris P; Lopez-Estraño C; Chung KT
Toxicol In Vitro; 2007 Dec; 21(8):1663-71. PubMed ID: 17826028
[TBL] [Abstract][Full Text] [Related]
38. Participation of cytochrome P450 in mutagenic activation of the carcinogen 3'-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene and its N-demethylated compounds by rat liver.
Mori Y; Niwa T; Toyoshi K
Mutat Res; 1983 Oct; 122(1):13-22. PubMed ID: 6413856
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
40. Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A).
Altuntas TG; Park SB; Kharasch ED
Chem Res Toxicol; 2004 Mar; 17(3):435-45. PubMed ID: 15025515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
